Blueprint Medicines Corp (NASDAQ:BPMC)
| 95.17 Delayed Data As of 3:59pm ET |  -0.59 / -0.62%Today’s Change | 56.00 Today|||52-Week Range 125.61 | -15.14% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 11.4M | 27.8M | 21.4M | 44.5M | |
| Depreciation And Amortization | 948.0K | 1.6M | 1.6M | 4.2M | ||
| Operating Expenses | Gross Income | -- | -- | -- | -- | -- |
| General Expenses | 62.1M | 98.8M | 171.1M | 287.3M | ||
| Research And Development | 48.6M | 81.1M | 144.7M | 243.6M | ||
| Total Operating Expenses | 63.0M | 100.3M | 172.7M | 291.5M | ||
| Non-Operating Expenses | Operating Income | -51.6M | -72.6M | -151.2M | -247.0M | |
| Extraordinary Charge | -445.0K | 0.00 | 0.00 | 0.00 | ||
| Interest Expense On Debt | 696.0K | 469.0K | 221.0K | 73.0K | ||
| Other Expenses | 16.0K | 551.0K | 3.3M | 10.5M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -52.8M | -72.5M | -148.1M | -236.6M | |
| Preferred Dividend | -3.2M | 0.00 | 0.00 | 0.00 | ||
| Net Income | -52.8M | -72.5M | -148.1M | -236.6M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 18.2M | 27.5M | 37.8M | 43.9M | |
| Shares To Calculate EPS Diluted | 18.2M | 27.5M | 37.8M | 43.9M | ||
| Earnings Per Share | EPS | -$3.07 | -$2.64 | -$3.92 | -$5.39 | |
| EPS Diluted | -$3.07 | -$2.64 | -$3.92 | -$5.39 | ||
